SEPTEMBER 7, 2021
FOR IMMEDIATE RELEASE
For further information, please contact:
VP of Marketing and Community Outreach
Diagnostic Biochips Inc.
Tel: +1 443-764-8035
Experienced marketing and web professional will lead strategic marketing plans for the innovative company.
Glen Burnie, Maryland – July 28, 2021 – Diagnostic Biochips Inc. is pleased to announce Nancy Palmer as Vice President of Marketing and Community Outreach aligning with the company’s ongoing drive to enable therapies and cures for neurological disorders and diseases. Nancy will lead the development of strategic marketing plans promoting sales growth and client satisfaction. Specific responsibilities include planning, development, and implementation of the organization’s marketing, communication outreach, and public relations activities. In this newly formed role for Diagnostic Biochips, she will also lead our efforts towards engaging the broader community ensuring that our priorities are aligned to areas that have the highest potential to improve peoples’ lives.
Nancy Palmer has been working in marketing and web development for the last 30 years for innovative global companies, most recently as the director of art and web services at KVH Industries Inc., headquartered in Middletown, RI. Nancy has expertise in managing multi-disciplined designers in vertical markets with B2B and B2C connections and marketing highly technical products. In addition, she has completed professional studies at RISD (Web Design and Development), Rhode Island College (Graphic Design/Photography), and Bryant University (Project Management Training) to continue to learn and grow in an ever-changing digital and professional environment. Nancy thrives on tailoring marketing requirements to the customers’ needs thus ensuring a creative new solution to every challenge.
Nancy is excited to begin her new role at Diagnostic Biochips as the VP of Marketing and Community Outreach and looks forward to working alongside these talented innovative individuals. Working with people who are truly making a difference in the health and welfare of emerging new neurotech treatments by allowing researchers to do their research rather than deal with the IT of science, is a very rewarding prospect for her.
“I am thrilled to be able to work on introducing Diagnostic Biochips and their next-generation probe and cloud-based analysis platforms into the market and look forward to forming lasting partnerships with other foundations to aid in the advancement of neuroscience and enable therapies and cures for neurological disorders and diseases,” says Nancy Palmer. “Now that’s something you don’t have the opportunity to say every day!”
“We are thrilled to have Nancy join the team in this newly formed role” says Greg Alden, president and CEO, “Nancy’s 20+ year background in marketing and especially in e-marketing, web, and managing complex highly technical products is a perfect match for where we are going. In addition to her marketing duties, Nancy will be leading our efforts into the broader community of potential partners that have the ability to impact people effected by neurodegenerative diseases and disorders”
In her new role at Diagnostic Biochips, Nancy will be responsible for leading all marketing and new partnership roles to further promote DBC’s ground-breaking new products and facilitate new research in many neuroscience and electrophysiology fields. Nancy will be based in Warren, RI, where she resides with her Aussiedoodle, Sailor. She loves hiking, boating, kayaking, and traveling to visit new locations
Diagnostic Biochips is a privately held provider of miniaturized high-channel count probes for recording circuit-level neural activity. This smaller, less invasive, technology shows great promise in the fields of pre-clinical neuroscience, brain-computer interface, and human clinical applications.
About Diagnostic Biochips Inc.
Diagnostic Biochips’ (DBC) is making brain diagnostics more cost-effective and accessible to academic, research and medical communities. DBC is accelerating the development and application of innovative technologies by providing access to brain data and advancing neuroscience to enable therapies and cures for neurological disorders and diseases. Researchers will be able to produce a revolutionary new picture of the brain that, for the first time, shows how individual cells and complex neural circuits interact in both time and space. Diagnostic Biochips was founded in 2013 and has been continually expanding its neurosensor capabilities. Diagnostic Biochips is Based in Glen Burnie, Maryland with a regional sales office in Austin, Texas.